Sunday, September 13, 2026

USD/EUR Bearish Momentum: 0.94% Down In The Last 10 Sessions

ViaNews Editorial Team

October 11, 2023

USD/EUR Bearish Momentum: 0.94% Down In The Last 10 Sessions

(VIANEWS) - USD/EUR (USDEUR) has been up by 0.94% for the last 10 sessions. At 08:07 EST on Wednesday, 11 October, USD/EUR (USDEUR) is $0.94.

USD/EUR's yearly highs and lows, it's 6.314% up from its 52-week low and 9.144% down from its 52-week high.

Volatility

USD/EUR's last week, last month's, and last quarter's current intraday variation average was a negative 0.25%, a positive 0.03%, and a positive 0.31%, respectively.

USD/EUR's highest amplitude of average volatility was 0.25% (last week), 0.29% (last month), and 0.31% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, USD/EUR's Forex is considered to be overbought (>=80).

News about

  • Usd/jpy treading water near 148.60 as investors sniff out US inflation figures. According to FXStreet on Wednesday, 11 October, "The USD/JPY continues to soar high above the 200-day Simple Moving Average (SDMA), which is currently riding up into the 139.00 chart region, with technical support for the pair currently sitting near 147.00 from the 50-day SMA.", "The long-term trend outlook for the USD/JPY is exceedingly bullish, with the Greenback trading well above the median against the Yen. "
  • Usd/jpy technical analysis: demand for buying safe havens - 10 October 2023. According to DailyForex on Tuesday, 10 October, "Accordingly, the USD/JPY currency pair jumped towards the resistance level of 149.23 before settling around the level of 148.70 at the time of writing the analysis. ", "Therefore, USD/JPY is likely to continue rising as buyers target the next major resistance level at 151.96 (October 22 high). "
  • Usd/jpy drops on risk-aversion spurred on middle-east tensions, falling US bond yields. According to FXStreet on Monday, 9 October, "The USD/JPY remains neutral to upward bias, with price action remaining above the Ichimoku Cloud (Kumo). ", "On the other hand and the path of least resistance, the USD/JPY could test the 150.00 figure, but first it needs to conquer 149.00"
  • Usd/jpy price analysis: struggles to capitalize on modest intraday bounce from one-week low. According to FXStreet on Tuesday, 10 October, "A generally positive risk tone is seen undermining the safe-haven Japanese Yen (JPY) and turning out to be a key factor lending some support to the USD/JPY pair. ", "From a technical perspective, the USD/JPY pair now seems to have found acceptance below the 100-period Simple Moving Average (SMA) on the 4-hour chart. "
  • Usd/jpy oscillates at around 148.60 amidst dovish fed remarks, risk-on impulse. According to FXStreet on Tuesday, 10 October, "Nevertheless, the USD/JPY rally was capped by the US Treasury bond yields plunge as the 10-year benchmark note sits at 4.632%, dropping 17 basis points since Monday."

More news about USD/EUR (USDEUR).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Keeps Flowing as Enterprise Adoption and Government Contracts Validate the Bet
A late-August surge of nine-figure funding rounds (Socure, Stability AI, Generalist AI, Gatik, Regent Craft, Emerald AI, Owner) shows venture capital still pouring into AI infrastructure, identity/fintech, and autonomy, even as public-market sentiment stays jumpy — Palantir's stock fell 6% the same week it landed the Army's TITAN contract. UiPath's raised guidance and strong Q2 results, alongside efficiency breakthroughs like Multiverse Computing's model compression, point to real enterprise monetization catching up to the funding hype.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
JPMorgan Chase & Co.
Both facts record the same attribute (net_income) for JPMorgan Chase & Co. in the identical fiscal period (Q1 2026) and observation date (2026-03-31), but report values that differ by approximately 1 billion times: $16,494,000,000 vs $16.49. These cannot both be true simultaneously. The discrepancy suggests either a unit mismatch (e.g., one is total net income, the other earnings per share mislabeled as net_income), a decimal point error, or data entry corruption. For the same entity, attribute, and time period, only one value can be correct.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,280 source documents archived
Query this data → isubstrate.com